ConductScience.org, home

Trial · NCT04043299

Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes

NCT04043299, Phase 3, Unknown, Makerere University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes. Trials, record NCT04043299. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04043299

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
NCT number
NCT04043299
Status
Unknown
Phases
Phase 3
Enrollment
1,108 participants, estimated
Lead sponsor
Makerere University
Conditions
Fetal Distress, Birth Asphyxia
Interventions
100% Oxygen, 21% oxygen
First posted
2019-08-02
Last updated
2020-03-26

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNormalization of the fetal heart rate30 minutesThe fetal heart rate will be between 120 to 160 beats per minute
SecondaryBirth AsphyxiaAt 5 minutes after birth
Five minute Apgar score of less than 7 at 5 minutes. Apgar Score refers to Appearance, pulse, grimace, activity and respiration. Each of these 5 elements are scored from 0-2 where by 0 is the worst score meaning absence of the parameter while 2 is the best score. A total of 0 means that the newborn has no signs of life, 1-6 refers to an infant with asphyxia while infants with scores of 7 to 10 are considered normal.
SecondaryHypoxic Ischemic encephalopathy24 hours and 7 days after birth
Hypoxic ischemic encephalopathy defined by Thompson Scores of 15 or more. This score is made of 9 signs assessed on a scale of 0-3. These are tone, level of consciousness, fits, posture, moro reflex, grasp reflex, suck, respiration and fontanel. Tone, level of consiciousness and posture are scored on a scale of 0-3 while the rest are scored on a scale of 0-2. A score of 0 for each individual item means normal while 2 or 3 refers to more severe problems. The lower the score, the better for a newborn.The maximum total score is 22 and scores of less than 10 are considered normal. However in this study, we shall consider scores of 15 or more as hypoxic ischemic encephalopathy.
SecondaryNeonatal AcidosisWithin 5 minutes of birthNeonatal acidosis defined by cord artery lactate of more than 5.5mmol/l taken after delivery
SecondaryStatus of newborn7 days after birthStatus of newborn indicating whether baby is alive or dead

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers13

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
7856671BACKGROUNDPubMed
11172187BACKGROUNDPubMed
16689989BACKGROUNDPubMed
17467589BACKGROUNDPubMed
21278499BACKGROUNDPubMed
23199150BACKGROUNDPubMed
23235574BACKGROUNDPubMed
23761161BACKGROUNDPubMed
24696860BACKGROUNDPubMed
27050656BACKGROUNDPubMed

1 to 10 of 13

See all 13 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04043299

GET https://conductscience.org/api/trials/v1/NCT04043299/registered